Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Coloplast A/S is a Danish multinational company that specializes in the development and manufacture of medical devices and services. The company's core business operates within the healthcare sector, offering products and services that focus on ostomy care, urology, continence care, and wound and skin care. Founded in 1957 and headquartered in Humlebæk, Denmark, Coloplast has established a strong presence in numerous countries, serving healthcare professionals and patients around the globe. Its strategic positioning is supported by a commitment to innovation and close collaboration with healthcare professionals to ensure the efficacy and safety of its offerings. Coloplast's competitive strengths derive from its comprehensive product portfolio and strong expertise in chronic care solutions.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Coloplast A/SEli Lilly
Last price
€65.32$1,273.46
Currency
EUR
USD
€14B$1.2T
39.0443.86
€1.64$29.79
0.550.45
€3.08$6.69
4.81%0.53%
Sector
HealthHealth
Employees
17,21350,000
Ticker
€COLOB$LLY
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €COLOB or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.